Erik N Newman1, Rafael Firszt2. 1. University of Utah School of Medicine, 100 N Mario Capecchi Dr., Salt Lake City, UT, 84108, USA. erik.newman@hsc.utah.edu. 2. Tanner Clinic, Salt Lake City, UT, 84107, USA.
Abstract
PURPOSE OF REVIEW: The development of food allergies is increasingly being recognized as a post-solid organ transplant complication. In this article, we review the spectrum of post-transplant food allergy development and the proposed mechanisms for de novo food allergies and the clinical significance they pose. RECENT FINDINGS: The development of new food allergies is disproportionately associated with pediatric liver transplants, where it occurs in up to 38% of select populations. The mechanism of food allergy development is not completely understood; however, it is likely promoted by unbalanced immune suppression. De novo food allergy development is a common complication of solid organ transplants with the highest risk occurring in pediatric liver transplant recipients. There are likely multiple mechanisms for food allergy development including passive transfer of membrane-bound IgE and lymphocytes from donor to recipient, as well as loss of food tolerance and active development of new food allergies. The optimal management of food allergies following organ transplants has not been well researched but may include changing the immune suppression regimen if the food allergy does not resolve without intervention.
PURPOSE OF REVIEW: The development of food allergies is increasingly being recognized as a post-solid organ transplant complication. In this article, we review the spectrum of post-transplant food allergy development and the proposed mechanisms for de novo food allergies and the clinical significance they pose. RECENT FINDINGS: The development of new food allergies is disproportionately associated with pediatric liver transplants, where it occurs in up to 38% of select populations. The mechanism of food allergy development is not completely understood; however, it is likely promoted by unbalanced immune suppression. De novo food allergy development is a common complication of solid organ transplants with the highest risk occurring in pediatric liver transplant recipients. There are likely multiple mechanisms for food allergy development including passive transfer of membrane-bound IgE and lymphocytes from donor to recipient, as well as loss of food tolerance and active development of new food allergies. The optimal management of food allergies following organ transplants has not been well researched but may include changing the immune suppression regimen if the food allergy does not resolve without intervention.
Entities:
Keywords:
Food allergy; Food allergy epidemiology; Food allergy management; Organ transplant; Organ transplantation; Post-transplant; Post-transplantation
Authors: Toral A Kamdar; Sarah Peterson; Claudia H Lau; Carol A Saltoun; Ruchi S Gupta; Paul J Bryce Journal: J Allergy Clin Immunol Pract Date: 2014-08-29
Authors: F Catal; E Topal; M A Selimoglu; H Karabiber; A Baskıran; E Senbaba; I Varol; S Yılmaz Journal: Allergol Immunopathol (Madr) Date: 2014-09-06 Impact factor: 1.667
Authors: Pattraporn Satitsuksanoa; Kirstin Jansen; Anna Głobińska; Willem van de Veen; Mübeccel Akdis Journal: Front Immunol Date: 2018-12-12 Impact factor: 7.561
Authors: C Caruso; E Pinter; E Poli; F Ferri; M Merli; S Colantuono; G Mennini; F Melandro; G Rumi; R Galandrini; S Ginanni Corradini Journal: Allergy Asthma Clin Immunol Date: 2019-02-21 Impact factor: 3.406